NewLimit, founded by Coinbase CEO Brian Armstorng, raises $130M to develop age-reversing treatments

Newlimit increased a number of $ 130 million bm, which aims to increase people that people can lead to a healthy life by preparing the cells genetically.

Nat Friedman, Daniel Gross and Hosla, also returned the Founders of the Supportors, Capital capitalElad Clay, Garry Tan, Patrick Collison and others. Fundraise comes two years after the company $ 40 million series a.

For more than four years, CEO Brian Armstrong (described above), former GV partner Blake Bryers and stem cell professor Jacob Kimel, youth features have made an important progress to restore elderly cells.

Speaking to Bryers TechCrunch, the company discovered three prototype medicines that reprogramming liver cells. Newlimit laboratory experiments said, demonstrating this rejuvenation, can restore the ability to operate the oil and alcohol.

The company measures the progress by acknowledging how a younger person responds to the substances of cells and an elderly person. Bryers said that an elderly liver cell lastly in the epigenetic raising of Newlaf is similar to a younger cell.

Newlimit, Newlimit is still a few years away from human trials.

Meanwhile, the company wants to continue preparing a new anti-aging drug using the AI ​​model and then the most prospect of the drug created. “The AI ​​model allows us to fulfill all the practices in the simulation, and then only the most promising subsections.”

Other remarkable biotech beginnings develop drugs aiming to increase life Retro biosphaciTwo years ago, Openai CEO has been reported to $ 180 million and a number of dollars in a number of dollars; and altos laboratories, this has initiated In 2022, it is $ 3 billion and is supported by Jeff Bezos.